Giuseppe Ambrosiano

Plain English
Researchers studied the complications occurring in patients with coeliac disease at four hospitals in Italy over roughly 12 years. They found that while complicated coeliac disease was rare, affecting only about 0.49% of patients, it had a high mortality rate, with five of the fourteen patients who developed complications dying. This highlights the need for close monitoring of coeliac patients, as severe complications can happen any time after diagnosis. Who this helps: This helps coeliac disease patients and their doctors by emphasizing the importance of regular follow-ups.

Plain English
This study looked at two groups of patients with complicated celiac disease: those who do not improve with a gluten-free diet right after diagnosis (Type A) and those who initially improve but then relapse (Type B). They found that 37 out of 87 patients with complications died, with 30 deaths in Type A and 7 in Type B, indicating that Type A cases have a much higher mortality rate. This research highlights that patients with complicated celiac disease face serious health risks, and understanding the differences between these two patterns can better inform treatment and management. Who this helps: This helps patients with celiac disease and their doctors in making more informed treatment decisions.

Plain English
This study looked at a condition called non-celiac wheat sensitivity (WS), where people have symptoms related to eating wheat but do not have celiac disease. Researchers found that among 276 patients diagnosed with WS, many showed signs like anemia, weight loss, and higher rates of food allergies compared to controls. It was also noted that WS patients fall into two groups: one group has symptoms similar to celiac disease, and the other has symptoms similar to food allergies. Who this helps: This helps patients who struggle with wheat-related symptoms but do not have celiac disease.

Plain English
This study looked at how effective abdominal ultrasound (US) is in diagnosing celiac disease (CD) in patients who showed symptoms but had negative blood test results. Out of 524 patients, 71 were considered for further testing, and the ultrasound showed a high accuracy: it identified signs in 92% of those who were later confirmed to have celiac disease, while nearly all (98%) of those without the disease were accurately identified as negative. This matters because it offers a reliable method to diagnose celiac disease in cases where blood tests fail to provide clear answers. Who this helps: This benefits patients who have symptoms of celiac disease but negative blood test results.

Plain English
This study looked at a type of wheat called C173 to see if it could be safer for people with celiac disease, who cannot eat gluten. Researchers tested how the wheat affected small intestine samples from 19 celiac disease patients and found that C173 was less harmful to the intestine’s structure compared to common wheat, even though it still triggered an immune response. This is important because it suggests that breeding wheat with less gluten could help reduce the damage to the intestines of celiac patients without eliminating their immune response. Who this helps: Patients with celiac disease.

Plain English
This study looked at adults with irritable bowel syndrome (IBS) to see how many had hypersensitivity to cow's milk and gluten. They found that 25% of the IBS patients had food hypersensitivity, and those individuals showed higher levels of specific markers in their stool, suggesting inflammation. This matters because identifying food hypersensitivity can help tailor treatments and improve the quality of life for patients struggling with IBS symptoms. Who this helps: Patients with irritable bowel syndrome.

Plain English
This study looked at a new method for diagnosing celiac disease (CD) using a test that checks for specific antibodies in samples from intestinal biopsies. Researchers found that this method was very accurate, with a sensitivity of 98% and specificity of 99%, compared to lower rates from traditional blood tests. This is important because it could help diagnose patients who have CD but show no signs in blood tests or intestinal damage, ensuring they get the right treatment. Who this helps: Celiac disease patients who might be misdiagnosed or undiagnosed.

Plain English
This study looked at how well a new blood test could identify food hypersensitivity in patients with irritable bowel syndrome (IBS). The researchers found that 20% of the 120 IBS patients tested had food hypersensitivity, particularly to cow's milk and wheat, and they showed significant improvement when following an elimination diet. The new test correctly identified food hypersensitivity in 86% of cases, which is better than existing methods. Who this helps: This benefits patients with IBS who may have undiagnosed food hypersensitivities.

Plain English
This study looked at celiac disease patients who are on a gluten-free diet and found that many still had intestinal damage and new gastrointestinal symptoms. Out of 69 patients, those with ongoing symptoms showed significant intestinal damage, with 85% experiencing villous atrophy compared to just 33% of symptom-free individuals. This matters because it highlights that even on a gluten-free diet, patients can continue to suffer from complications and unusual symptoms. Who this helps: This helps celiac disease patients and their doctors by identifying ongoing issues that require attention.

Plain English
This study looked at blood tests for a type of antibody called IgA anti-actin in patients with coeliac disease to see how well it can indicate damage to the intestine. They found that these antibodies were present in 69% of patients with mild damage and 85.3% of those with severe damage, showing that the test can accurately reflect the severity of intestinal injury. This matters because it can help better monitor and manage patients' conditions, especially those who still have symptoms despite following a gluten-free diet. Who this helps: This helps doctors and patients with coeliac disease.

Plain English
This study looked at the safety of infliximab, a treatment for active Crohn's disease. It found that while infliximab is effective, it can lead to serious side effects, including infections and autoimmune disorders, and there are concerns about a potential increased risk of cancer and lymphoma. Understanding these risks is crucial for doctors in deciding the best treatment options for patients. Who this helps: Patients with Crohn's disease and their doctors.